Aquestive Therapeutics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for AQST, updated each market day.
AQST AI Sentiment
AI predicts Aquestive Therapeutics, Inc. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Aquestive Therapeutics, Inc. Common Stock
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
Sector
Exchange
Market Cap
$508,927,854
Cap Tier
Employees
147
Headquarters
WARREN, NJ
Listed Since
July 25, 2018
Website
AQST Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
AQST Volatility
Aquestive Therapeutics, Inc. Common Stock has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
